Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma: Do they give any prognostic information in clinical practice?

Scandinavian Journal of Urology and Nephrology

Volumn 38, Issue 3, 2004, Pages 225-230

  Kallio, J P ^a   Mahlamaki E H ^a   Helin, H ^a   Karhu, R ^a   Kellokumpu Lehtinen, P ^a   Tammela, T L J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Comparative genomic hybridization; Prognosis; Proliferation; Renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHROMOSOME 12; CHROMOSOME 3; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EVALUATION; GENE DELETION; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR CLASSIFICATION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; HUMANS; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 2542516950     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590310025399     Document Type: Article

References (22)

1. Robson C, Churchill B, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297-301.
2. Hofmockel G, Tsatalpas P, Muller H, Dammrich J, Poot M, Maurer-Schulze B, et al. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer 1995; 76: 296-306.
3. Thrasher J, Paulson D. Prognostic factors in renal cancer. Urol Clin North Am 1993; 20: 247-62.
4. Nativ O, Sabo E, Raviv G, Madjar S, Halachmi S, Moskovitz B. The impact of tumor size on clinical outcome of patients with localized renal cell carcinoma treated by radical nephrectomy. J Urol 1997; 158: 729-32.
5. Roosen J, Engel R, Jensen R, Kvist E, Schou G. Renal cell carcinoma: prognostic factors. Br J Urol 1994; 74: 160-4.
6. Gerdes J, Li L, Schluter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138: 867-73.
7. Jochum W, Schröder S, Al-Taha R, August C, Gross A, Berger J, et al. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. Cancer 1996; 77: 514-21.
8. Tannapfel A, Hahn H, Katalinic A, Fietkau R, Kuhn R, Wittekind C. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 1996; 77: 164-71.
9. Zhou M, Rubin M. Molecular markers for renal cell carcinoma: impact on diagnosis and treatment. Semin Urol Oncol 2001; 19: 80-7.
10. Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-21.
11. Moch H, Presti J, Jr, Sauter G, Buchholz N, Jordan P, Mihatsch M, et al. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 1996; 56: 27-30.
12. Lahiri D, Nurnberger J, Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
13. Kallioniemi O, Kallioniemi A, Piper J, Isola J, Waldman F, Gray J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10: 231-43.
14. Störkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma. Cancer 1997; 80: 987-9.
15. Fuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63.
16. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, et al. TNM staging of renal cell carcinoma. Cancer 1997; 80: 992-3.
17. Rautiainen E, Haapasalo H, Sallinen P, Rantala I, Helen P, Helin H. Histone mRNA in-situ hybridization in astrocytomas: a comparison with PCNA, MIB-1 and mitoses in paraffin-embedded material. Histopathology 1998; 32: 43-50.
18. Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997; 57: 2765-80.
19. Jiang F, Desper R, Papadimitriou C, Schaffer A, Kallioniemi O, Richter J, et al. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridisation data. Cancer Res 2000; 60: 6503-9.
20. Bissig H, Richter J, Desper R, Meier V, Schraml P, Schäffer A, et al. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridisation. Am J Pathol 1999; 155: 267-74.
21. Junker K, Moravek P, Podhola M, Weirich G, Hindermann W, Janitzky V, et al. Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridisation: correlation with clinical and histological data. Int J Oncol 2000; 17: 903-8.
22. Cattoretti G, Becker M, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin-embedded sections. J Pathol 1992; 168: 357-63.